Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

292 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Genomic surveillance of SARS-CoV-2 positive passengers on flights from China to Italy, December 2022.
Novazzi F, Giombini E, Rueca M, Baj A, Fabeni L, Genoni A, Ferrante FD, Gramigna G, Gruber CEM, Boutahar S, Minosse C, Butera O, Pasciuta R, Focosi D, Colombo A, Antinori A, Girardi E, Vaia F, Maggi F. Novazzi F, et al. Among authors: focosi d. Euro Surveill. 2023 Jan;28(2):2300008. doi: 10.2807/1560-7917.ES.2023.28.2.2300008. Euro Surveill. 2023. PMID: 36695479 Free PMC article.
A multicentre, patient- and assessor-blinded, non-inferiority, randomised and controlled phase II trial to compare standard and torque teno virus-guided immunosuppression in kidney transplant recipients in the first year after transplantation: TTVguideIT.
Haupenthal F, Rahn J, Maggi F, Gelas F, Bourgeois P, Hugo C, Jilma B, Böhmig GA, Herkner H, Wolzt M, Doberer K, Vossen M, Focosi D, Neuwirt H, Banas M, Banas B, Budde K, Viklicky O, Malvezzi P, Rostaing L, Rotmans JI, Bakker SJL, Eller K, Cejka D, Pérez AM, Rodriguez-Arias D, König F, Bond G; TTVguideTX consortium partners. Haupenthal F, et al. Among authors: focosi d. Trials. 2023 Mar 22;24(1):213. doi: 10.1186/s13063-023-07216-0. Trials. 2023. PMID: 36949445 Free PMC article. Clinical Trial.
SARS-CoV-2 evolution during persistent infection in a CAR-T recipient shows an escape to both sotrovimab and T-cell responses.
Mazzetti P, Spezia PG, Capria AL, Freer G, Sidoti M, Costarelli S, Cara A, Rosellini A, Frateschi S, Moscato G, Franconi I, Curcio M, Vatteroni ML, Lai M, Quaranta P, Focosi D, Sani S, Pistello M. Mazzetti P, et al. Among authors: focosi d. J Clin Virol Plus. 2023 Jun;3(2):100149. doi: 10.1016/j.jcvp.2023.100149. Epub 2023 Apr 21. J Clin Virol Plus. 2023. PMID: 37128202 Free PMC article. No abstract available.
292 results